RHOEN-KLINIKUM AG (RHK.DE) Stock Analyst Earnings Estimates
FRA:RHK - Deutsche Boerse Ag - DE0007042301 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.402B 3.08% | 1.446B 3.14% | 1.464B 1.24% | 1.567B 7.04% | 1.643B 4.85% | 1.727B 5.11% | 1.86B 7.70% | 1.98B 6.45% | |
| EBITDA YoY % growth | 101.029M 13.20% | 102.686M 1.64% | 106.664M 3.87% | 111.17M 4.22% | 115.62M 4.00% | 120.98M 4.64% | 141.72M 17.14% | 156.11M 10.15% | |
| EBIT YoY % growth | 30.829M 58.54% | 33.086M 7.32% | 41.064M 24.11% | 45.888M 11.75% | 52.581M 14.59% | 58.159M 10.61% | 70.345M 20.95% | 82.769M 17.66% | |
| Operating Margin | 2.20% | 2.29% | 2.80% | 2.93% | 3.20% | 3.37% | 3.78% | 4.18% | |
| EPS YoY % growth | N/A 32.69% | N/A -27.54% | N/A 76.00% | 0.63 40.91% | 0.66 4.84% | 0.75 13.85% | 0.85 13.50% | 1.00 17.34% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2019 Q2Q % growth | 0.10 | 0.07 | 0.03 | 41.44% |
| Q2 2019 Q2Q % growth | 0.18 | 0.11 | 0.07 | 62.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 395.54M 9.63% | % | ||
| Q2 2024 Q2Q % growth | 392.694M 7.10% | % | ||
| Q1 2024 Q2Q % growth | 382.819M 5.90% | % | ||
| Q4 2023 Q2Q % growth | 375.024M -1.01% | % | ||
| Q3 2023 Q2Q % growth | 360.793M 1.33% | % | ||
| Q2 2023 Q2Q % growth | 366.662M 0.76% | % | ||
| Q1 2023 Q2Q % growth | 361.5M 4.09% | % | ||
| Q4 2022 Q2Q % growth | 378.833M 1.99% | % | ||
| Q3 2022 Q2Q % growth | 356.061M 2.39% | % | ||
| Q2 2022 Q2Q % growth | 363.903M 4.90% | % | ||
| Q1 2022 Q2Q % growth | 347.289M 3.39% | % | ||
| Q4 2021 Q2Q % growth | 371.459M 8.79% | % | ||
| Q3 2021 Q2Q % growth | 347.747M -0.12% | % | ||
| Q2 2021 Q2Q % growth | 346.895M 2.65% | % | ||
| Q1 2021 Q2Q % growth | 335.909M 0.99% | % | ||
| Q4 2020 Q2Q % growth | 341.444M 2.51% | % | ||
| Q3 2020 Q2Q % growth | 348.176M 6.60% | % | ||
| Q2 2020 Q2Q % growth | 337.926M 5.61% | % | ||
| Q1 2020 Q2Q % growth | 332.613M 2.59% | % | ||
| Q4 2019 Q2Q % growth | 333.086M | 336.33M | -3.244M | -0.96% |
| Q2 2019 Q2Q % growth | 319.967M | 349.21M | -29.243M | -8.37% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 6.9% | 13.41% |
| Revenue | N/A | N/A | 1.16% | 1.16% |